<\/p>\n
Lupimeb<\/strong> er en oral mebendazole 100 mg chewable tablet<\/strong> fra Lupin<\/strong>. Mebendazole is a WHO Essential Medicine for pinworm, roundworm, hookworm, and whipworm<\/strong>. Standard voksendose: 100 mg as a single dose for pinworm, repeat in 2 weeks<\/strong>. For mixed infection or whipworm: 100 mg twice daily for 3 days<\/strong>.<\/p>\n<\/div>\n<\/div>\n \ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n Lupimeb<\/strong> is mebendazole 100 mg chewable from Lupin<\/strong>. Mebendazole was the first benzimidazole anthelmintic in routine human use and remains a WHO Essential Medicine. Albendazole has overtaken it as first-line in most settings, but mebendazole has a niche role: it is preferred in patients with concurrent moderate-to-severe hepatic impairment (less hepatic metabolism) and is the agent of choice in some paediatric whipworm protocols.<\/p>\n Mebendazole binds \u03b2-tubulin<\/strong> in parasite cells, preventing microtubule polymerisation. This blocks parasite glucose uptake and depletes glycogen stores — the worm starves over 2–3 days. Mebendazole’s oral bioavailability is very low (< 10%), which is therapeutically useful: high concentrations stay in the gut lumen where intestinal worms live, with minimal systemic exposure.<\/p>\nHvorfor bestille fra MedsBase<\/h3>\n
What is Lupimeb?<\/h2>\n
Mekanisme for virkning<\/h2>\n
Lupimeb indications and dose<\/h2>\n